From: COVID-19 clinical outcomes and nationality: results from a Nationwide registry in Kuwait
Kuwaiti (N = 294) | Non-Kuwaiti (N = 829) | Overall (N = 1123) | |
---|---|---|---|
Any comorbidity | |||
At least one comorbidity | 140 (47.6%) | 214 (25.8%) | 354 (31.5%) |
No comorbidities | 154 (52.4%) | 615 (74.2%) | 769 (68.5%) |
Hypertension | |||
No | 213 (72.4%) | 721 (87.0%) | 934 (83.2%) |
Yes | 81 (27.6%) | 108 (13.0%) | 189 (16.8%) |
Diabetes | |||
No | 227 (77.2%) | 728 (87.8%) | 955 (85.0%) |
Yes | 67 (22.8%) | 101 (12.2%) | 168 (15.0%) |
Asthma | |||
No | 269 (91.5%) | 806 (97.2%) | 1075 (95.7%) |
Yes | 25 (8.5%) | 23 (2.8%) | 48 (4.3%) |
Total Comorbiditya | |||
0 | 154 (52.4%) | 615 (74.2%) | 769 (68.5%) |
1 | 55 (18.7%) | 132 (15.9%) | 187 (16.7%) |
2 | 38 (12.9%) | 57 (6.9%) | 95 (8.5%) |
3 | 30 (10.2%) | 19 (2.3%) | 49 (4.4%) |
4 | 14 (4.8%) | 6 (0.7%) | 20 (1.8%) |
5 | 2 (0.7%) | 0 (0%) | 2 (0.2%) |
6 | 1 (0.3%) | 0 (0%) | 1 (0.1%) |